ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,850, issued on Jan. 20, was assigned to CureVac Netherlands B.V. (Amsterdam).
"Cancer vaccines for breast cancer" was invented by Ronald Hans Anton Plasterk (Amsterdam).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to the field of cancer, in particular breast cancer. In particular it relates to the field of immune system directed approaches for tumor reduction and control. Some aspects of the invention relate to vaccines, vaccinations and other means of stimulating an antigen specific immune response against a tumor in individuals. Such vaccines comprise neoantigens resulting from frameshift mutations that bring out-of-frame se...